Insider Transactions in Q3 2023 at Windtree Therapeutics Inc (WINT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2023
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+4.14%
|
$2,500
$1.02 P/Share
|
|
Sep 26
2023
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+4.32%
|
$0
$0.9 P/Share
|
|
Aug 23
2023
|
Daniel E. Geffken Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,033
+48.31%
|
-
|
|
Aug 23
2023
|
Eric Curtis SVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,667
+47.95%
|
-
|
|
Aug 23
2023
|
Steven Simonson SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,867
+47.64%
|
-
|
|
Aug 23
2023
|
Robert A Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,033
+48.8%
|
-
|
|
Aug 23
2023
|
Mark Strobeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+50.0%
|
-
|
|
Aug 23
2023
|
Leslie J. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,033
+48.8%
|
-
|
|
Aug 23
2023
|
Craig Fraser President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,867
+46.45%
|
-
|